Growth in human immunodeficiency virus type 1- infected children treated with protease inhibitors

@article{Steiner2001GrowthIH,
  title={Growth in human immunodeficiency virus type 1- infected children treated with protease inhibitors},
  author={Felicitas Steiner and Christian Kind and Christoph Aebi and Claire-Anne Wyler-Lazarevitch and J J Cheseaux and Christoph Rudin and Luciano Molinari and David Nadal},
  journal={European Journal of Pediatrics},
  year={2001},
  volume={160},
  pages={611-616}
}
Abstract. To determine the long-term impact of antiretroviral treatment (ART) including a protease inhibitor (PI) on growth in children infected with the human immunodeficiency virus type 1 (HIV-1), a prospective multi-centre study was conducted in Switzerland on HIV-1-infected children treated with ritonavir (350 mg/m2 twice a day) or nelfinavir (20–30 mg/kg three times a day) in addition to two nucleoside reverse transcriptase inhibitors. Length or height of HIV-1-infected children from… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi.

  • Tropical medicine & international health : TM & IH
  • 2010
VIEW 4 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED